Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00168896
Status:
UNKNOWN
Last Update Posted:
2006-02-14
First Post:
2005-09-09
Brief Title:
A Study for Small Cell Lung Cancer SCLC in Extensive Disease Stage
Sponsor:
Charite University Berlin Germany
Organization:
Charite University Berlin Germany
Study Overview
Official Title:
A Randomised Phase IIIII Study to Compare the Combination of Carboplatin Plus Irinotecan Vs the Combination of Carboplatin Plus Etoposide for SCLC in Extensive Disease Stage
Status:
UNKNOWN
Status Verified Date:
2001-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Comparison of two combination chemotherapies in the treatment of patients with SLCL
Detailed Description:
Comparison of two combination chemotherapies in the treatment of patients with SLCL
The combination chemotherapies for this study are Carboplatin plus Irinotecan versus Carboplatin plus Etoposide
The combination chemotherapies for this study are Carboplatin plus Irinotecan versus Carboplatin plus Etoposide
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None